Could a common immune treatment ease sickle cell pain?
NCT ID NCT01757418
First seen Nov 17, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study tested whether a medicine called Intravenous Immunoglobulin (IVIG) is safe and works to shorten painful episodes (crises) in people with sickle cell disease. About 300 people aged 6 to 65 took part. The goal was to see if IVIG could reduce how long the pain lasts and the amount of pain medicine needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.